enVVeno Medical (NVNO) Accumulated Expenses (2017 - 2026)
enVVeno Medical's quarterly Accumulated Expenses came in at $382000.0 in Q1 2026, down 43.74% quarter-over-quarter from $679000.0 in Q4 2025.
enVVeno Medical has reported Accumulated Expenses for 9 years, with the latest figure at $382000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $382000.0; the trailing twelve-month figure through Mar 2026 stood at $382000.0 (changed N/A YoY), and the FY2025 full-year result was $679000.0, up 12.42% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $382000.0, down from $679000.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $679000.0 in Q4 2025, with the low at $294000.0 in Q1 2022.
- Average Accumulated Expenses over 4 years is $466600.0, with a median of $382000.0 recorded in 2026.
- Year-over-year, Accumulated Expenses tumbled 44.71% in 2022 and grew 12.42% in 2025.
- Tracing NVNO's Accumulated Expenses over 4 years: stood at $374000.0 in 2022, then surged by 61.5% to $604000.0 in 2024, then advanced by 12.42% to $679000.0 in 2025, then sank by 43.74% to $382000.0 in 2026.
- The last three Accumulated Expenses figures came in at $382000.0 (Q1 2026), $679000.0 (Q4 2025), and $604000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 382,000.00 |
| Dec 31, 2025 | 679,000.00 |
| Dec 31, 2024 | 604,000.00 |
| Jun 30, 2022 | 374,000.00 |
| Mar 31, 2022 | 294,000.00 |
| Dec 31, 2021 | 525,000.00 |
| Sep 30, 2021 | 358,644.00 |
| Jun 30, 2021 | 412,466.00 |
| Mar 31, 2021 | 531,749.00 |
| Dec 31, 2020 | 1.17 Mn |
| Sep 30, 2020 | 287,672.00 |
| Jun 30, 2020 | 457,409.00 |
| Mar 31, 2020 | 363,304.00 |
| Dec 31, 2019 | 333,438.00 |
| Sep 30, 2019 | 500,166.00 |
| Jun 30, 2019 | 381,995.00 |
| Mar 31, 2019 | 438,534.00 |
| Dec 31, 2018 | 412,871.00 |
| Sep 30, 2018 | 635,331.00 |
| Jun 30, 2018 | 1.18 Mn |
| Dec 31, 2017 | 903,594.00 |